Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Nasdaq Real Time Price USD

Bolt Biotherapeutics, Inc. (BOLT)

Compare
0.3600
-0.0354
(-8.95%)
At close: April 4 at 4:00:00 PM EDT
0.3888
+0.03
+(8.00%)
After hours: April 4 at 7:03:09 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -15.94M

Q1'24

Q2'24

Q3'24

Q4'24

-20M
-15M
-10M
-5M
0
5M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1.00
1.12 Average
0.3600 Current
1.25 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2222
Avg. Estimate -0.32-0.33-1.17-0.63
Low Estimate -0.33-0.34-1.32-0.7
High Estimate -0.32-0.32-1.03-0.56
Year Ago EPS -0.28-0.56-1.65-1.17

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 3333
Avg. Estimate 1.02M987.67k3.79M6.73M
Low Estimate 800k600k2.1M700k
High Estimate 1.14M1.28M5.04M15.16M
Year Ago Sales 5.27M1.27M7.69M3.79M
Sales Growth (year/est) -80.60%-22.54%-50.70%77.46%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -0.51-0.59-0.4-0.35
EPS Actual -0.28-0.56-0.4-0.42
Difference 0.230.03-0.01-0.07
Surprise % 45.37%4.55%-1.27%-20.00%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.32-0.33-1.17-0.63
7 Days Ago 00-0.89-0.79
30 Days Ago 00-0.89-0.79
60 Days Ago 00-0.89-0.79
90 Days Ago 00-0.89-0.79

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days ------2
Up Last 30 Days ------1
Down Last 7 Days ----2--
Down Last 30 Days ----21

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
BOLT -16.07%41.07%28.79%46.38%
S&P 500 6.68%6.74%9.91%14.34%

Upgrades & Downgrades

Reiterates HC Wainwright & Co.: Neutral to Neutral 3/25/2025
Maintains Stifel: Hold to Hold 3/25/2025
Reiterates HC Wainwright & Co.: Neutral 11/13/2024
Reiterates HC Wainwright & Co.: Neutral 8/15/2024
Downgrade Leerink Partners: Outperform to Market Perform 5/15/2024
Downgrade Jones Trading: Buy to Hold 5/15/2024

Related Tickers